Please provide your email address to receive an email when new articles are posted on . In recent years, we have made significant strides in our understanding of the pathogenesis of asthma. As a ...

A recent study published in Frontiers in Immunology discussed how injury and abnormal repair of the airway epithelium drive chronic obstructive pulmonary disease (COPD) and asthma. Study: Mechanisms ...

A collaborative effort between researchers at the Henan Academy of Innovations in Medical Science, Zhengzhou University, and ...

Two monoclonal antibodies directed toward different interleukin (IL) targets produced wildly different results in randomized phase II trials involving asthma. On the plus side, an IL-33 inhibitor ...

Asthma is characterized by eosinophilic airway inflammation and elevated serum immunoglobulin E (IgE) levels. Due to these pathologic features, the foundation of asthma treatment has historically been ...

The US Food and Drug Administration (FDA) has approved tezepelumab-ekko (Tezspire) as a first in class treatment for severe asthma in adults and pediatric patients aged 12 years and older. It is not ...

Patients with severe asthma have poor disease control and frequent exacerbations, even with the use of high-dose inhaled glucocorticoids. Although interleukin-23 is implicated in the pathogenesis of ...

SAN DIEGO -- Treatment with an investigational oral Bruton's tyrosine kinase (BTK) inhibitor was associated with numerical decreases in loss of asthma control (LOAC) events for patients with poorly ...